Atypical development of the executive attention network in children with chromosome 22q11.2 deletion syndrome

Journal of Neurodevelopmental Disorders

Volumn 3, Issue 1, 2011, Pages 76-85

  Stoddard, Joel ^a   Beckett, Laurel ^b   Simon, Tony J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Attention networks task; Chromosome 22q11.2 deletion syndrome; Cognitive control

Indexed keywords

EID: 79952701892     PISSN: 18661947     EISSN: 18661955     Source Type: Journal    
DOI: 10.1007/s11689-010-9070-3     Document Type: Article

References (50)

1. Antshel KM, AbdulSabur N, Roizen N, Fremont W, Kates WR. Sex differences in cognitive functioning in velocardiofacial syndrome (VCFS). Dev Neuropsychol. 2005; 28(3): 849-69.
2. Antshel KM, Shprintzen R, Fremont W, Higgins AM, Faraone SV, Kates WR. Cognitive and psychiatric predictors to psychosis in velocardiofacial syndrome: a 3-year follow-up study. J Am Acad Child Adolesc Psychiatry. 2010; 49(4): 333-44.
3. Baker K, Baldeweg T, Sivagnanasundaram S, Scambler P, Skuse D. COMT Val108/158 Met modifies mismatch negativity and cognitive function in 22q11 deletion syndrome. Biol Psychiatry. 2005; 58(1): 23-31.
4. Bassett AS, Chow EW. 22q11 deletion syndrome: a genetic subtype of schizophrenia. Biol Psychiatry. 1999; 46(7): 882-91.
5. Bearden CE, Jawad AF, Lynch DR, Sokol S, Kanes SJ, McDonald-McGinn DM, et al. Effects of a functional COMT polymorphism on prefrontal cognitive function in patients with 22q11. 2 deletion syndrome. Am J Psychiatry. 2004; 161(9): 1700-2.
6. Bilder RM, Volavka J, Czobor P, Malhotra AK, Kennedy JL, Ni X, et al. Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. Biol Psychiatry. 2002; 52(7): 701-7.
7. Bish JP, Ferrante SM, McDonald-McGinn D, Zackai E, Simon TJ. Maladaptive conflict monitoring as evidence for executive dysfunction in children with chromosome 22q11. 2 deletion syndrome. Dev Sci. 2005; 8(1): 36-43.
8. Blasi G, Mattay VS, Bertolino A, Elvevag B, Callicott JH, Das S, et al. Effect of catechol-O-methyltransferase val158met genotype on attentional control. J Neurosci. 2005; 25(20): 5038-45.
9. Botvinick MM, Braver TS, Yeung N, Ullsperger M, Carter C, Cohen JD. Conflict monitoring: computational and empirical studies. In: Posner MI, editor. Cognitive neuroscience of attention. New York: The Guilford Press; 2004. p. 91-102.
10. Carter CS, van Veen V. Anterior cingulate cortex and conflict detection: an update of theory and data. Cogn Affect Behav Neurosci. 2007; 7(4): 367-79.
11. Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S, et al. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet. 2004; 75(5): 807-21.
12. De Smedt B, Devriendt K, Fryns JP, Vogels A, Gewillig M, Swillen A. Intellectual abilities in a large sample of children with velo-cardio-facial syndrome: an update. J Intellect Disabil Res. 2007; 51(Pt 9): 666-70.
13. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci. 2001; 98(12): 6917-22.
14. Eriksen B, Eriksen C. Effects of noise letters upon the identification of a target letter in a nonsearch task. Percept Psychophys. 1974; 16(1): 143-9.
15. Fan J, McCandliss BD, Sommer T, Raz A, Posner MI. Testing the efficiency and independence of attentional networks. J Cogn Neurosci. 2002; 14(3): 340-7.
16. Fan J, McCandliss B, Fossella J, Flombaum J, Posner M. The activation of attentional networks. Neuroimage. 2005; 26(2): 471-9.
17. Gothelf D, Eliez S, Thompson T, Hinard C, Penniman L, Feinstein C, et al. COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11. 2 deletion syndrome. Nat Neurosci. 2005; 8(11): 1500-2.
18. Gothelf D, Hoeft F, Hinard C, Hallmayer JF, Stoecker JV, Antonarakis SE, et al. Abnormal cortical activation during response inhibition in 22q11. 2 deletion syndrome. Hum Brain Mapp. 2007; 28(6): 533-42.
19. Gothelf D, Schaer M, Eliez S. Genes, brain development and psychiatric phenotypes in velo-cardio-facial syndrome. Dev Disabil Res Rev. 2008; 14(1): 59-68.
20. Gratton G, Coles MG, Donchin E. Optimizing the use of information: strategic control of activation of responses. J Exp Psychol Gen. 1992; 121(4): 480-506.
21. Joober R, Gauthier J, Lal S, Bloom D, Lalonde P, Rouleau G, et al. Catechol-O-methyltransferase Val-108/158-Met gene variants associated with performance on the Wisconsin Card Sorting Test. Arch Gen Psychiatry. 2002; 59(7): 662-3.
22. Karayiorgou M, Simon TJ, Gogos JA. 22q11. 2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia. Nat Rev Neurosci. 2010; 11(6): 402-16.
23. Kates WR, Antshel KM, Abdulsabur N, Colgan D, Funke B, Fremont W, et al. A gender-moderated effect of a functional COMT polymorphism on prefrontal brain morphology and function in velo-cardio-facial syndrome (22q11. 2 deletion syndrome). Am J Med Genet B Neuropsychiatr Genet. 2006; 141B(3): 274-80.
24. Kates WR, Krauss BR, Abdulsabur N, Colgan D, Antshel KM, Higgins AM, et al. The neural correlates of non-spatial working memory in velocardiofacial syndrome (22q11. 2 deletion syndrome). Neuropsychologia. 2007; 45(12): 2863-73.
25. Konrad K, Neufang S, Thiel CM, Specht K, Hanisch C, Fan J, et al. Development of attentional networks: an fMRI study with children and adults. Neuroimage. 2005; 28(2): 429-39.
26. Lewandowski KE, Shashi V, Berry PM, Kwapil TR. Schizophrenic-like neurocognitive deficits in children and adolescents with 22q11 deletion syndrome. Am J Med Genet B Neuropsychiatr Genet. 2007; 144B(1): 27-36.
27. Malhotra AK, Kestler LJ, Mazzanti C, Bates JA, Goldberg T, Goldman D. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry. 2002; 159(4): 652-4.
28. Mayr U, Awh E, Laurey P. Conflict adaptation effects in the absence of executive control. Nat Neurosci. 2003; 6(5): 450-2.
29. Murphy KC, Owen MJ. Velo-cardio-facial syndrome: a model for understanding the genetics and pathogenesis of schizophrenia. Br J Psychiatry. 2001; 179: 397-402.
30. Nackley AG, Shabalina SA, Tchivileva IE, Satterfield K, Korchynskyi O, et al. Human catechol-o-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science. 2006; 314: 1930-3.
31. Nestor PG, Kubicki M, Spencer KM, Niznikiewicz M, McCarley RW, Shenton ME. Attentional networks and cingulum bundle in chronic schizophrenia. Schizophr Res. 2007; 90(1-3): 308-15.
32. Oskarsdottir S, Vujic M, Fasth A. Incidence and prevalence of the 22q11 deletion syndrome: a population-based study in Western Sweden. Arch Dis Child. 2004; 89(2): 148-51.
33. Posner MI. Orienting of attention. Q J Exp Psychol. 1980; 32(1): 3-25.
34. Posner MI, Petersen SE. The attention system of the human brain. Annu Rev Neurosci. 1990; 13: 25-42.
35. Robin NH, Shprintzen RJ. Defining the clinical spectrum of deletion 22q11. 2. J Pediatr. 2005; 147(1): 90-6.
36. Rockers K, Ousley O, Sutton T, Schoenberg E, Coleman K, Walker E, et al. Performance on the Modified Card Sorting Test and its relation to psychopathology in adolescents and young adults with 22q11. 2 deletion syndrome. J Intellect Disabil Res. 2009; 53(7): 665-76.
37. Rueda MR, Fan J, McCandliss BD, Halparin JD, Gruber DB, Lercari LP, et al. Development of attentional networks in childhood. Neuropsychologia. 2004; 42(8): 1029-40.
38. Shashi V, Keshavan MS, Howard TD, Berry MN, Basehore MJ, Lewandowski E, et al. Cognitive correlates of a functional COMT polymorphism in children with 22q11. 2 deletion syndrome. Clin Genet. 2006; 69(3): 234-8.
39. Sigurdsson T, Stark KL, Karayiorgou M, Gogos JA, Gordon JA. Impaired hippocampal-prefrontal synchrony in a genetic mouse model of schizophrenia. Nature. 2010; 464(7289): 763-7.
40. Simon TJ. A new account of the neurocognitive foundations of impairments in space, time and number processing in children with chromosome 22q11. 2 deletion syndrome. Dev Disabil Res Rev. 2010; 14(1): 52-8.
41. Simon TJ, Bish JP, Bearden CE, Ding L, Ferrante S, Nguyen V, et al. A multilevel analysis of cognitive dysfunction and psychopathology associated with chromosome 22q11. 2 deletion syndrome in children. Dev Psychopathol. 2005; 17(3): 753-84.
42. Sobin C, Kiley-Brabeck K, Daniels S, Blundell M, Anyane-Yeboa K, Karayiorgou M. Networks of attention in children with the 22q11 deletion syndrome. Dev Neuropsychol. 2004; 26(2): 611-26.
43. Swanson JM. School-based assessments and interventions for ADD students. Irvine: KC Publishing; 1992.
44. Takarae Y, Schmidt L, Tassone F, Simon TJ. Catechol-O-methyltransferase polymorphism modulates cognitive control in children with chromosome 22q11. 2 deletion syndrome. Cogn Affect Behav Neurosci. 2009; 9(1): 83-90.
45. Tezenas Du Montcel S, Mendizabai H, Ayme S, Levy A, Philip N. Prevalence of 22q11 microdeletion. J Med Genet. 1996; 33(8): 719.
46. Townsend J, Ashby F. The stochastic modeling of elementary psychological processes. Cambridge: CUP Archive; 1983.
47. Tunbridge EM, Harrison PJ, Weinberger DR. Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond. Biol Psychiatry. 2006; 60(2): 141-51.
48. Urbanek C, Neuhaus A, Opgen-Rhein C, Strathmann S, Wieseke N, Schaub R, et al. Attention network test (ANT) reveals gender-specific alterations of executive function in schizophrenia. Psychiatry Res. 2009; 168(2): 102-9.
49. Wang K, Fan J, Dong Y, Wang C, Lee T, Posner M. Selective impairment of attentional networks of orienting and executive control in schizophrenia. Schizophr Res. 2005; 78(2-3): 235-41.
50. Woodin MF, Wang PP, Aleman D, McDonald-McGinn DM, Zackai EH, Moss EM. Neuropsychological profile of children and adolescents with the 22q11. 2 microdeletion. Genet Med. 2001; 3(1): 34-9.